ClinicalTrials.Veeva

Menu

Prognostic Value of Sympathetic Modulation in Patients With Heart Failure

U

University of Sao Paulo General Hospital

Status

Unknown

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT02047409
2013/07651-7 (Other Identifier)
2010/50048-1 (Other Identifier)
EDT-13001-PD

Details and patient eligibility

About

The purpose of this study is to determine whether oscillatory pattern of sympathetic nerve activity muscle is an efficient index for the prognosis of patients with heart failure.

Enrollment

160 estimated patients

Sex

All

Ages

30 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with systolic heart failure and New York Heart Association (NYHA)
  • Ischemic, hypertensive, or idiopathic etiology
  • Left ventricular ejection fraction less than 40%

Exclusion criteria

  • Neuromuscular, Orthopedic, Neurologic and Pulmonary Diseases
  • Renal failure
  • Diabetes mellitus type II

Trial contacts and locations

1

Loading...

Central trial contact

Maria Urbana P B Rondon, PhD; Edgar Toschi Dias, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems